A recent study published in The Lancet HIV, conducted by the Burnet Institute and WHO, showed a critical issue regarding funding cuts on the global HIV response.
Peter Williams, CEO of SMS Tech (Smart Manufacturing Solutions Technology), walks us through NHS-driven evolution in healthcare management, an aspect of adapting excellence.
Bryn Sage, CEO of remote patient monitoring provider Inhealthcare, explains how the company’s digital health technology is helping to ease pressures across the NHS, reduce hospital admissions, and improve patients’ health outcomes.
Heidi J Larson, along with contributors from the Vaccine Confidence Project, discuss the complex factors influencing decision-making around vaccines and what can be done to improve public trust.
Dr Deborah Lee from Dr Fox Online Pharmacy discusses men’s mental health, including common barriers to seeking help and the measures needed to improve overall awareness and support.
Virtual wards are helping to improve the delivery of care and save clinicians valuable time and resources; we hear how Baywater Healthcare’s virtual ward solution is helping to support more patients and improve their overall care.
Michael Wong and Amy Campbell from the Physician-Patient Alliance for Health & Safety reflect on the fourth World Sepsis Congress discussion, which focused on ways to improve long-term health outcomes post sepsis.
Mat Oram, CEO and Co-Founder of AdviseInc, discusses the importance of data literacy and the steps organisations can take to truly understand how data can support their goals.
A team of neuroscientists, neurosurgeons and engineers have created a speech prosthesis that can interoperate a person's brain signals and convert them into speech.
In an era marked by technological leaps and a shift towards patient-centred care, a virtual ward has emerged as a pioneering solution that bridges the gap between traditional hospital setups and the convenience of remote healthcare.
A new groundbreaking blood test, p-tau217, holds potential as an Alzheimer's disease indicator. When incorporated into a two-step process, it demonstrates exceptional accuracy in detecting or ruling out brain amyloidosis, a crucial early sign.
